VERtebral Fracture Treatment Comparisons in Osteoporotic Women (VERO)
Read time: 1 mins
Last updated:16th Oct 2012
The primary purpose of participation in this study is to answer whether teriparatide is superior to risedronate in reducing the occurrence of new vertebral fractures during 24 months of therapy.
|Study start date||2012-10-16|